Ganesh Kaundinya - Momenta Pharmaceuticals Insider

MNTA -- USA Stock  

USD 30.23  0.28  0.93%

Co-Founder, Chief Scientific Officer and Sr. VP of Research
Dr. Ganesh Venkataraman Kaundinya, Ph.D., is Chief Operating Officer, Chief Scientific Officer of the Company. He is a cofounder of the Company and was the Company Chief Scientific Officer since September 2007. From September 2007 until his appointment as the Chief Operating Officer, Dr. Kaundinya was also a Senior Vice President of the Company. From April 2005 to September 2007, Dr. Kaundinya was the Company Senior Vice President, Research, and from January 2002 until April 2005, Dr. Kaundinya served as the Company Vice President, Technology
Age: 50  Founder Since 2017      
617-491-9700  http://www.momentapharma.com
Kaundinya received his M.S. and Ph.D. in Chemical Engineering from the Massachusetts Institute of Technology.

Ganesh Kaundinya Latest Insider Activity

Management Efficiency

The company has return on total asset (ROA) of (14.55) % which means that it has lost $14.55 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (29.51) % meaning that it created substantial loss on money invested by shareholders.

Similar Executives

Found 1 records

FOUNDER Since

Neil BodickFlexion Therapeutics
2017

Entity Summary

Momenta Pharmaceuticals, Inc., a biotechnology company, focuses on developing generic versions of complex drugs, biosimilars, and novel therapeutics for autoimmune diseases in the United States. Momenta Pharmaceuticals, Inc. was founded in 2001 and is headquartered in Cambridge, Massachusetts. Momenta Pharmaceuticals operates under Drug Manufacturers - Specialty Generic classification in USA and traded on NASDAQ. It employs 279 people.Momenta Pharmaceuticals (MNTA) is traded on NASDAQ in USA. It is located in 675 West Kendall Street and employs 279 people.

Momenta Pharmaceuticals Leadership Team

Bennett Shapiro, Director
James Anderson, President
Craig Wheeler, CEO, MBA
Georges Gemayel, Director, Ph.D
Matthew Ottmer, COO
Elizabeth Stoner, Director
John Bishop, President, MBA
JoseCarlos GutierrezRamos, Director, Ph.D
Bruce Leicher, President
James Sulat, Chairman, MBA
Corey Fishman, Director
Jim Anderson, President
James Roach, President, Ph.D
Young Kwon, President, Ph.D
Bruce Downey, Director
JoAnn Beltramello, President
Steven Gilman, Director
Anthony Manning, President, Ph.D
Marsha Fanucci, Director, MBA
Ganesh Kaundinya, Founder
Ian Fier, President, MBA
Richard Shea, CFO, CPA
Michael Franken, President
Thomas Koestler, Director, Ph.D
Scott Storer, President, MBA

Stock Performance Indicators

Did you try this?

Run Equity Valuation Now
   

Equity Valuation

Check real value of public entities based on technical and fundamental data
All  Next Launch Equity Valuation

Build Optimal Portfolios

Align your risk with return expectations
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Please see also Stocks Correlation. Please also try Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
vendors/bower_components/jquery.easy-pie-chart/dist/jquery.easypiechart.min.js">